首页|基于微流控芯片的阿尔茨海默病模型构建和应用研究进展

基于微流控芯片的阿尔茨海默病模型构建和应用研究进展

扫码查看
阿尔茨海默病(Alzheimer's disease,AD)是一种进行性神经退行性疾病,与大脑的思维、学习和记忆等功能障碍有关。AD病理特征多、病因复杂,构建合适的病理模型对于AD的研究至关重要。微流控芯片技术将多种功能单元集成于芯片上,可实现接近生理环境的微环境控制,在AD病理模型构建、早期诊断以及药物筛选等方面具有良好的应用价值。本文基于AD的病理学特征,从细胞类型、培养方式和芯片结构等角度重点综述了AD微流控芯片模型的构建,以及微流控芯片在AD应用中的研究进展,为进一步阐明AD机制和药物开发提供参考。
Advances in the construction of models and applications of Alzheimer's disease based on microfluidic chips
Alzheimer's disease(AD)isa progressive neurodegenerative disease associated with dysfunctions related to thinking,learning,and memory of the brain.AD has multiple pathological characteristics with complicated causes,constructing a suitable pathological model is crucial for the research of AD.Microfluidic chip technology integrates multiple functional units on a chip,which can realize microenvironmental control similar to the physiological environment.It is well applied in the construction of pathological model,early diagnosis as well as drug screening of AD.This paper focuses on the construction of AD microfluidic chips model from the perspective of cell type,culture formats and the chips structure as well as the research progress of microfluidic chips in AD application based on the pathological characteristics of AD,which will provide a reference for further elucidation of AD mechanism and drug development.

microfluidic chipAlzheimer's diseasemodel constructionpathological mechanismdrug screening

游飘雪、陈兰、沈淑琦、晁亮、王辉、洪战英

展开 >

福建中医药大学药学院,福建福州 350122

海军军医大学药学院,上海市药物(中药)代谢产物研究重点实验室,上海 200433

微流控芯片 阿尔茨海默病 模型构建 病理机制 药物筛选

国家自然科学基金资助项目国家自然科学基金资助项目

8217377781872829

2024

药学学报
中国药学会 中国医学科学院药物研究所

药学学报

CSTPCD北大核心
影响因子:1.274
ISSN:0513-4870
年,卷(期):2024.59(6)
  • 108